Method Validation of an Ultra-High-Performance Liquid Chromatography (UHPLC) for the Bioequivalence Study of Rifampicin
Allen Jasper D. Diño, Essel N. Tolosa, Ailyn M. Yabes, Noel S. Quiming, Leonila A. Estole-Casanova, Ma. Stephanie Fay S. Cagayan, Cecilia A. Jimeno · 2025
Read Method Validation of an Ultra-High-Performance Liquid Chromatography (UHPLC) for the Bioequivalence Study of Rifampicin by Allen Jasper D. Diño, Essel N. Tolosa, Ailyn M. Yabes, Noel S. Quiming, Leonila A. Estole-Casanova, Ma. Stephanie Fay S. Cagayan, Cecilia A. Jimeno (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12795710.txt.
Description
Seven authors in the Philippines test a fast drug assay for rifampicin in a 2025 paper. Generic forms of the tuberculosis drug must prove they match the reference product, and that proof needs a quick, exact blood test. The team checked an ultra high performance liquid chromatography method against rules at home and abroad.
Plasma was cleaned by protein precipitation with methanol and ascorbic acid, then run through a compact column with ultraviolet detection. The three minute run used a shifting mix of water and acetonitrile at set temperatures. Checks covered selectivity, linearity, sensitivity, accuracy, precision, and carry over, and the results met the bioanalytical standards in the rules. The method now readies the lab for bioequivalence trials of generic rifampicin.
Catalog record
| CREATOR | Allen Jasper D. Diño, Essel N. Tolosa, Ailyn M. Yabes, Noel S. Quiming, Leonila A. Estole-Casanova, Ma. Stephanie Fay S. Cagayan, Cecilia A. Jimeno |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 22 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |